Catalyst
Slingshot members are tracking this event:
Mallinckrodt (MNK) Will Initiate Company-Sponsored Clinical Trial of H.P. Acthar Gel in Treatment of Amyotropic Lateral Sclerosis in the first half of 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| MNK | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 03, 2017
Occurred Source:
https://clinicaltrials.gov/ct2/show/NCT03068754?term=NCT03068754&rank=1
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Als, Acthar Gel
